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b-Lactoglobulin (b-Lg) is the major protein fraction of bovine whey serum and a primary gelling agent. b-
Lg has a high nutritional value, is stable at low pH being highly resistant to proteolytic degradation in the
stomach, besides, it has the ability of acting as an encapsulating agent. This study aims at assessing the
ability of b-Lg nanostructures to associate a nutraceutical - i.e. riboﬂavin - and release it in a controlled
manner throughout an in vitro gastrointestinal (GI) system. For this reason b-Lg nanostructures loaded
with riboﬂavin were critically characterized in terms of their morphology (i.e. size, polydispersity, z-
potential and shape) by dynamic light scattering (DLS) and transmission electron microscopy (TEM), and
efﬁciency to associate to riboﬂavin through spectroﬂuorimetry. Furthermore, these nanocomplexes were
evaluated in an in vitro GI model, simulating the physiological conditions. Stable b-Lg nanostructures
were obtained at pH 6, of spherical shape, characterized by particle size of 172±1 nm, low polydispersity
(i.e. PDI of 0.06±0.02), z-potential of 32±3 mV and association efﬁciency (AE) of 26±1 %. b-Lg nano-
structures showed to be stable upon their passage throughout stomach (i.e. particle size, PDI and z
potential of 248±10 nm, 0.18±0.03 and 18±3 mV, respectively). Concerning their passage throughout the
intestine, such nanostructures were mostly degraded in the duodenum. Regarding riboﬂavin, a release of
about 11 % was observed after their passage through stomach, while 35 %, 38 % and 5 % were the released
percentages of the total riboﬂavin associated observed after passage through duodenum, jejunum and
ileum, respectively. Hence, b-Lg nanostructures showed to be suitable carriers for riboﬂavin until the
intestine, where their degradation occurs. b-Lg also showed to be structurally stable, under food simulant
conditions (yoghurt simulant, composed of 3 % acetic acid), over 14 days, with a protective effect upon
riboﬂavin activity, releasing it in a 7 day period.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Whey is a byproduct of cheese production, relatively inexpen-
sive with a high nutritional value containing a variety of proteins
with unique physical, chemical and functional properties
(Cerqueira et al., 2014; McIntosh et al., 1998; Ramos et al., 2015). b-
Lactoglobulin (b-Lg) is the main protein in whey (i.e. 50% of whey
protein composition), with a well-known ability to form three-
dimensional networks (i.e. gel formation), foams and stable nano-
structures. These nanostructures can associate to other compounds,eira).thus improving their adsorption in the intestine by increasing
residence time, enhancing contact with epithelial membrane,
therefore contributing to a higher bioavailability (Diarrassouba,
2013; Giroux & Britten, 2011; Gunasekaran, Ko, & Xiao, 2007).
This lipocalin protein encompasses nine antiparallel b-barrels
with three a-helixes on the outer surface, a free thiol group,
responsible for its antioxidant activity and contains four binding
sites (the calix, the gap near the a-helix on the outer surface, the
dimer interface and the outer surface near tryptophane19-
aginine124), which makes b-Lg a suitable bio-based vehicle for
transportation of various functional compounds, particularly those
which are poorly soluble inwater and susceptible to degradation by
chemical and light reactions (such as riboﬂavin) (Diarrassouba,
2013; Diarrassouba, Liang, Remondetto, & Subirade, 2013; Giroux
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2007; Zimet & Livney, 2009).
Structures used in the nanometer scale exhibit a large surface
area-to-volume ratio and their physical and chemical interactions
inﬂuence their overall properties, in particular encapsulation of
nutraceuticals. For instance, a change in their pharmacokinetics
and biodistribution, contributes to the improvement of nutraceut-
icals’ solubility and bioavailability, thus preventing undesirable
chemical reactions and maintaining its activity until its release
(Cerqueira et al., 2014; Lingyun Chen, Remondetto, & Subirade,
2006; Ramos et al., 2015).
Riboﬂavin (also known as vitamin B2) is a biocompatible ﬂavin
that can easily be found in Nature (in wheat bran, meat, milk,
cheese and plant materials). This vitamin is essential for growth,
development and normal maintenance of the human body, but
very susceptible to light degradation and poorly soluble in water
(Ball, 2004; Cerqueira et al., 2014; Diarrassouba et al., 2013). On the
other hand, upon light activation, riboﬂavin can also cause damage
to DNA, proteins and other biomolecules. Therefore, this vitamin
can effectively act as a nutraceutical against antibiotic resistant
pathogens found in food products and in prevention of some types
of cancers (e.g. leukemia) (Diarrassouba et al., 2013). When inges-
ted, the b-Lg/riboﬂavin nanocomplex will be subjected to innu-
merous conditions (i.e. pH variations, enzymatic action, peristaltic
movements and temperature), in the gastrointestinal (GI) tract,
that can change their structure, thus reducing their effectiveness.
Therefore, it is crucial to evaluate the behavior of such nano-
complex in the GI tract physiological conditions in order to un-
derstand the effects on the nanostructure stability, in particular
regarding the release of riboﬂavin with the purpose of optimizing
its bioavailability (Cerqueira et al., 2014).
Studies were found in the literature addressing complexes made
fromwhey proteins and bioactive compounds under GI conditions.
Diarrassouba et al. (2013) studied the effects of GI pH conditions on
the stability of b-Lg/vitamin D3 nanocomplex. They concluded that
b-Lg/D3 nanocomplex is stable under acidic (4.0e2.5) and alkaline
(6.8e8.0) transitions, suggesting that it might be stable throughout
the GI tract transit. Picot and Lacroix (2004) studied the encapsu-
lation efﬁciency of biﬁdobacteria in whey protein-based micro-
capsules and their survival in simulated GI conditions. They
concluded that encapsulation of biﬁdobacteria provided a protec-
tive effect during the GI simulation (i.e. pH 1.9 and gastric enzymes
e in stomach simulation; and pH 7.5 and pancreatic and bile salts e
in intestinal simulation) tested at 37 C. Le Maux et al. (2013)
studied the b-Lg/linoleate complex under in vitro digestion condi-
tions (0.15 mol/L NaCl and pH 2.5 e gastric ﬂuid simulation; and
0.15 mol/L NaCl and pH 6.5 e duodenal ﬂuid simulation), linoleate
bioaccessibility, as well as its intracellular transport into intestinal
epithelial Caco-2 cell lines. They concluded that the formation of b-
Lg/linoleate complex modiﬁed the linoleate transport and delayed
the cytotoxicity of the fatty acids. However, the GI models used in
these studies only mimic the gastric and duodenal conditions being
poorly accurate regarding GI tract enzymatic conditions. Therefore,
the present work intends to go deeper in this matter in order to
better understand the behavior of bio-based nanostructures, as
well as the bioavailability of associated bioactive compounds, when
subjected to different physicochemical mechanisms. Hence, nano-
structures made from b-Lg and loaded with riboﬂavin were criti-
cally characterized in terms of their morphology (i.e. particle
diameter, polydispersity and z-potential, shape) by dynamic light
scattering (DLS) and transmission electron microscopy (TEM), and
the efﬁciency to associate riboﬂavin by spectroﬂuorimetry.
Furthermore, these nanocomplexes were evaluated through an
in vitro GI model, simulating the physiological conditions (i.e. pH,
enzymes, salts and temperature) and time in the stomach and smallintestine (including duodenum, jejunum and ileum) in order to
address the main challenges regarding the bioavailability of ribo-
ﬂavin and its controlled release in different GI conditions. This
study also provides information about the stability of such nano-
complexes when incorporated in water (used as control) and in a
food model system (i.e. yoghurt) during 14 days of storage, aiming
at their application in the food industry.
2. Materials and methods
2.1. Materials
Riboﬂavin with a purity 98% and bovine b-Lg containing var-
iants A and B (36.0 kDa) with a purity  90% (L0130), were pur-
chased as a lyophilized powder from SigmaeAldrich (St. Louis MO,
USA). Pepsin (600 U ml1) from porcine gastric mucosa, lipase
(40 U ml1), pancreatin from porcine pancreas (8  USP), bile
extract porcine, as well as gastric and small intestinal electrolyte
solution salts were also purchased from SigmaeAldrich (St. Louis
MO, USA). Ultrapure water (resistivity 18.2 MU/cm) was obtained
with a Milli-Q Ultrapure water puriﬁcation system (Millipore,
BedfordMA, USA). Sodium hydroxide (NaOH) and hydrochloric acid
(HCl) solutions were obtained from Panreac (Panreac Quimica SA,
Barcelona, Spain). Coomassie brilliant blue (250) (CBB) was pur-
chased from SigmaeAldrich (St. Louis MO, USA), whereas sodium
azide (NaN3) was obtained from Merck (Darmstadt, Germany). All
other chemicals were reagent-grade or higher, and were used
without further puriﬁcation.
2.2. Measurements
2.2.1. Dynamic light scattering
The particle diameter, polydispersity index (PDI) and z-potential
of protein solution were measured by dynamic light scattering
(DLS) using a Zetasizer Nano ZEN 3600 (Malvern Instruments,
Worcestershire, UK) equipped with a HeeNe laser of 632.8 nm and
4 mW. Measurements of DLS were collected applying backscatter
detection NIBS (Non-Invasive Back-Scatter) at 173, which reduces
multiple scattering and allows higher concentrations to be
measured (Rodrigues et al., 2015). Samples (1 mL) of unheated and
heated b-Lg solutions collected at different stages of in vitro
digestion were poured into disposable sizing cuvettes with a path
length of 12 mm for particle diameterand PDI determination and
into a folded capillary cell for z-potential analyses and measure-
ments were carried out, at least, in triplicate. To analyze the sam-
ples resulting from the in vitro digestion experiment, a dilution of a
1:100 (v/v) ratio was made in the appropriate pH conditions (pH 2
and 7 for stomach and small intestine, respectively) to avoid mul-
tiple scattering effects. The temperature of analysis was maintained
at 25.0 ± 0.5 C during measurement. Average diffusion coefﬁcients
were determined by the method of cumulants ﬁt and were trans-
lated into average particle diameters (Zavg) using StokeseEinstein
relationship (Rodrigues et al., 2015). PDI derived from cumulants
analysis of the DLSmeasurements was also evaluated and describes
the width or the relative variance of the particle diameter distri-
bution. The z-potential was performed with an angle of 17 by
measuring the velocity and direction of droplet movement in the
electric ﬁeld being calculated through the Smoluchowski model.
2.2.2. Transmission electron microscopy
The surface morphology of the b-Lg nanostructures was evalu-
ated by transmission electron microscopy (TEM) (Zeiss EM 902A
Thornwood, N.Y., USA) at an accelerating voltage of 50 and 80 kV.
The samples were previously prepared by dropping b-Lg samples
onto copper grids coated with carbon ﬁlm, followed by natural
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The samples were then negatively stained with uranyl acetate (2%
w/w) (Merck, Germany) for 15 s, and the grid was air-dried at room
temperature before introducing it in the electron microscope
(Bourbon et al., 2015; Pinheiro et al., 2015).2.2.3. Spectroﬂuorimetry
Spectroﬂuorimeter (Jasco FP6200, Tokyo, Japan) was used to
assess the association efﬁciency of riboﬂavin, and to quantify its
release over time during the in vitro digestion and stability assays.
This vitamin presents ﬂuorescence properties (Sa, da Silva, Jost, &
Spinelli, 2015), which enable its study on a spectroﬂuorimeter. All
samples were previously centrifuged at 5000 g, for 30min at 5 C to
separate the b-Lg nanostructures from free riboﬂavin in order to
avoid misleading results. The ﬂuorescence intensity spectra of su-
pernatants were then recorded between 480 and 650 nm, with an
excitation wavelength set to 450 nm.2.2.4. Native polyacrylamide gel electrophoresis
In order to understand the behavior of b-Lg in GI conditions, a
native polyacrylamide gel electrophoresis (native PAGE) was per-
formed. The native PAGE was carried out using the Mini-Protean II
dual slab cell system equipped with a PAC 300 power supply (Bio-
Rad Laboratories, Hercules, CA, USA). The resolving and stacking gel
contained 12% and 4% of polyacrylamide, respectively. The gels
were left in gentle agitation overnight in a solution of ethanol 50%
and acetic acid 10% and stained with CBB and destained with a 30
and 7% of ethanol and acetic acid solutions, respectively, according
to previous works (Bourbon et al., 2015; L. Chen & Subirade, 2005;
Rodrigues et al., 2015).2.3. b-Lg/riboﬂavin nanocomplex
2.3.1. Production
b-Lg nanostructures were prepared according to previously
optimized conditions (Branco, 2015) where various parameters
were assessed (i.e. protein and vitamin concentrations, time of
heating, centrifugal time and g force employed). Therefore, a so-
lution of b-Lg at 0.5% (w/v) was prepared via dissolution in ultra-
pure water and subsequently stirred for 2 h at room temperature,
and then pHwas adjusted to 6.0 with HCl (1mol/L) or NaOH (1mol/
L), as necessary. Afterward, the b-Lg solutionwas heated at 80 C for
10 min. A riboﬂavin solution was ﬁnally added to attain a ﬁnal
concentration of 0.0006% (v/v). During this process, the vitamin
solutionwas protected from light exposurewith aluminum foil. The
resulting solution was then cooled in ice for 15 min.2.3.2. Association efﬁciency
Association efﬁciency (AE) was assessed by comparing the total
riboﬂavin concentration (from riboﬂavin solution) with the con-
centration of riboﬂavin unattached to b-Lg. Primarily, 1 mL of both
riboﬂavin at 0.0006% (v/v) (riboﬂavin solution), and samples (b-Lg/
riboﬂavin nanocomplex) were placed into Eppendorf tubes and
centrifuged. Then, 0.1 mL of supernatant was collected and ﬂuo-
rescence spectral analysis was obtained. The maximum absorbance
peaks, from the ﬂuorescence spectra, of riboﬂavin and supernatant
were used to determine the riboﬂavin concentration (calculated
using an appropriate calibration curve of riboﬂavin:
y¼ 99,624xþ 8.3344, R2¼ 0.991; being y and x the absorbance and
concentration of free riboﬂavin, respectively) and the results were
used on Eq. (1).AEð%Þ ¼ CVit$total  CVit$free
CVit$total
*100; (1)
where CVit$total represents the concentration of riboﬂavin in solution
and CVit$free the concentration of free riboﬂavin separated from b-Lg
nanostructures The determinations were performed at least in
triplicate.
2.4. In vitro digestion
The in vitro digestion experiment was performed in a GI model
constituted by a double-walled water-jacketed reactor vessel
(10 cm internal diameter and 15 cm height), adapted from Pinheiro
et al. (2013). Primarily, the loss of activity of free riboﬂavin was
assessed in the in vitro GI model and it was observed that only
56 ± 10, 40 ± 8, 24 ± 3 and 16 ± 4% would reach the stomach,
duodenum, jejunum and ileum, respectively. These results conﬁrm
the necessity of its encapsulation in order to allow its protection
during the in vitro digestion. b-Lg/riboﬂavin solution (40 mL) was
inserted into the GI simulator, the temperature was set to 37 C and
appropriate secretions were continuously added, in order to mimic
the physiological conditions of the GI tract (i.e. stomach, duo-
denum, jejunum and ilium). All samples were taken at the end of
each phase. The in vitro digestion conditions are resumed in Table 1.
All pH transitions were accomplished by adding HCl (1 mol/L) and
sodium bicarbonate (1 mol/L) for gastric and small intestine pH
conditions, respectively.
2.5. Stability assessment
The stability of b-Lg/riboﬂavin nanocomplex was assessed in a
food model system solution composed by 3% of acetic acid at pH
3.65, to mimic yoghurt, according to the Commission Regulation
(EU) No 10/2011 for food simulants (European Commission, 2011),
and compared with the behavior of such nanocomplex in ultrapure
water (used as control). The stability test was conducted during a
predetermined period of time (14 days) through evaluation of
particle diameter, PDI and z-potential variation by DLS, release
proﬁle of riboﬂavin by spectroﬂuorimetry, and particle morphology
by TEM. Microorganism growth was prevented by adding 0.02% of
NaN3 (used as preservative) (Ramos et al., 2012) into the food
model system solution. All samples were analyzed immediately
after production, in triplicate.
2.6. Statistical analysis
All statistical analyses involving experimental data were per-
formed using Statistica software version 10.0.228.8 (StatSoft Inc.).
Statistical signiﬁcance (at p  0.05) was determined using one-way
ANOVA followed by post hoc.
Tukey's tests. Unless otherwise stated, all the following experi-
ments were run at least in triplicate and all measured parameters
are means of four experimental points.
3. Results and discussion
3.1. Particle characterization
The evaluation of particle diameter, PDI and z-potential allowed
the understanding of some structural changes that occur in b-Lg
nanostructure during the heating treatment and incorporation of
riboﬂavin. Characterization of b-Lg/riboﬂavin nanocomplex by DLS
is shown in Table 2.
These results demonstrate that unheated b-Lg solution, at pH 6,
Table 1
In vitro digestion conditions for the different digestion phases, using electrolyte solutions for gastric (GES - NaCl 4.8 g/L, KCl 2.2 g/L, CaCl2 0.22 g/L and NaHCO31.5 g/L) and small
intestine (SIES - NaCl 5 g/L, KCl 0.6 g/L and CaCl2 0.25 g/L) conditions.
Digestion phases Secretions Electrolyte solution Flow (mL/min) pH Time (h)
Stomach pepsin
lipase
100 mL of GES 0.3 from 4.8 to 1.7 2
Duodenum 30 mL of porcine bile extract at 4% (w/v)
15 mL of pancreatin solution
9 mL of SIES 0.6 6.5 1
Jejunum 20 mL of porcine bile extract 200 mL of SIES 2.1 6.8 1
Ileum e 150 mL of SIES 2.0 7.2 1
Table 2
Particle size, PDI and z-potential values obtained for b-Lg nanostructures before and after heating treatment, as well as after riboﬂavin association.
b-Lg Particle size (Zavr nm) PDI z-potential (mV)
Unheated 299 ± 25a 0.54 ± 0.02a 20 ± 5a
Heated (80 C, 10 min) 168 ± 3b 0.08 ± 0.03b 33 ± 7b
b-Lg/Riboﬂavin nanocomplex 172 ± 1b 0.06 ± 0.02b 32 ± 3b
Note: Means within a given column, labeled with the same superscript letter (a or b) do not statistically differ from each other (p > 0.05).
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high standard deviation obtained for particle diameter and PDI
values). This heterogeneity may be due to non-covalent linked
protein aggregates which are commonly observed on its native
form (Pereira, Souza, Cerqueira, Teixeira, & Vicente, 2010; Ramos
et al., 2014). This protein system appears to be on a semi-stable
state when looking to the z-potential value (20 ± 5 mV) e it is
considered that z-potential values above þ30 mV and
below 30 mV, for this kind of nanostructures, represent stable
colloidal systems (Diarrassouba, 2013; Moore & Cerasoli, 2010).
However, this colloidal stability can always be compromised with
interaction of oppositely charged polymers and particles. Dena-
turation was then promoted by heating the b-Lg solution (80 C for
10 min), which caused alterations on particle diameter, PDI and z-
potential. After heating, the protein solution became more stable
(z-potential changed from 20 ± 5 to 33 ± 7 mV) and homoge-
neous. Moreover, PDI values decreased from 0.54 ± 0.02 to
0.08 ± 0.03 and particle diameter was reduced approximately to
half of its initial value (i.e. decreased from 299 ± 25 to 168 ± 3 nm).
The heating process may allow dissolving some protein aggregates
that could be present in the native solution at ambient tempera-
ture, while also promoting structural rearrangements by breaking
at least some of the disulﬁde bonds, resulting in protein unfolding
and exposure of its sulfhydryl groups. The sulfhydryl groups may
form inter- and intra-molecular bonds by interacting with other
disulﬁde bonds which, together with inter-molecular interactions
between proteins, will determine protein aggregation (Pereira
et al., 2010). After cooling, aggregation of b-Lg occurs
(Kolakowski, Dumay,& Cheftel, 2001) through new intra-molecular
disulﬁde bonds leading to the reduction of particle diameter dis-
tribution. The addition of riboﬂavin did not produce signiﬁcant
(p > 0.05) changes in the particle diameter, PDI or z-potential values
(see Table 2). Incorporation of riboﬂavin into the solutionwas made
while b-Lg was on its molten globule state. At this state, the partial
unfolding of b-Lg and the increase in ﬂexibility of some structural
regions (but still preserving the calyx) enables the exposure of the
inner binding site, making it more easily accessible (Tavel, Moreau,
Bouhallab, Li-Chan, & Guichard, 2010) to riboﬂavin, which possibly
allowed its association to the protein network with an AE of
26 ± 1%. This value was relatively lower when compared with that
obtained by Azevedo, Bourbon, Vicente, and Cerqueira (2014),
which showed an AE of 56 ± 6% for riboﬂavin using nanoparticles
made from alginate/chitosan as base materials, besides a high
heterogeneity associated to these systems (Azevedo et al., 2014).
This difference could be explained by the nature of the differentencapsulating agents employed (in that case, the authors used the
combination of two polysaccharides for the nanostructures’ pro-
duction), as well as by the different production conditions (e.g. pH
of 4.6 and 4.9) applied. It is known that, despite the lack of toxicity,
the recommended daily dose (RDD) for riboﬂavin is approximately
1.2 mg (Horwitt, Harvey, Hills, & Liebert, 1949; Powers, 2003).
Therefore due to an AE of 26 ± 1%, the results show that 12% of the
RDD would reach the small intestine if 100 mL of a food product
was ingested, suggesting that this nanocomplex may ﬁnd applica-
tions as a food supplement system. Hence, it can be incorporated
into healthy food products that have already some content of
riboﬂavin in their composition in order to overcome potential
nutritional deﬁciencies.
Despite of the fact that the nanocomplex produced here showed
to be more stable than those reported elsewhere, comparisons
should be carefully made once conditions/compounds employed
and purposes vary signiﬁcantly (Pereira et al., 2010). Yi et al. (2014)
produced b-Lg/dextran nanoparticles for controlled release of b-
carotene. They obtained b-Lg/dextran nanoparticles with a mean
particle diameter of 68 ± 3 nm, PDI of 0.17 ± 0.03 and z-potential
of 14 ± 1 mV. They obtained a lower particle diameter than those
mentioned in this work. That can be explained by different sample
preparation or conditions used (i.e. nanostructures formed by the
mixture of different polymers - dextran and b-Lg - prepared at pH 7
and b-Lg at 1%). However the nanocomplex formed seems to be less
stable(z-potential of 14 ± 1 mV) according with the deﬁnition of
stability for colloidal systems aforementioned (Diarrassouba, 2013;
Moore& Cerasoli, 2010), thus being probably less suitable as carrier
systems for nutraceuticals, when compared with the results pre-
sented here for b-Lg nanostructures (Table 2). Chen and Subirade
(2005) produced chitosan/b-Lg coreeshell nanoparticles for
controlled release of nutraceuticals. They studied the inﬂuence of
pH on particle diameter and z-potential. At pH 6.1, they obtained a
particle diameter of 103 nm, PDI of 0.54 and z-potential of þ30 mV.
Despite the lower particle diameter obtained (which can be
explained by the nanocomplex formation between chitosan and b-
Lg) their nanosystem presented a high degree of heterogeneity
which suggests the existence of particles on other scale ranges.
Thus, the authors cannot assure the measurement of particles only
in the nanometer range.
3.2. In vitro digestion
During digestion, food undergoes two main processes (that
occur simultaneously): the inﬂuence of mechanical movements
Fig. 1. Native PAGE of b-Lg nanostructures loaded with riboﬂavin at different stages of
the GI tract: 1- native b-Lg (without heat treatment); 2- b-Lg/riboﬂavin nanocomplex;
3 and 5 stomach and duodenum control (GES and SIES, respectively); 4, 6, 7 and 8 - b-
Lg/riboﬂavin nanocomplex in stomach, duodenum jejunum and ileum, respectively.
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cles, and enzymatic action where macromolecules are hydrolyzed
to form more basic, smaller structures able to be subsequently
absorbed into the bloodstream (Guerra et al., 2012; Kong & Singh,
2008; Pinheiro, 2013).
In order to understand the behavior of b-Lg nanostructures
loaded with riboﬂavin in GI conditions, an in vitro GI model was
used to simulate as close as possible the human GI tract. Therefore,
said nanostructures were characterized in terms of their structure
(i.e. particle diameter, PDI and z-potential), capacity to associate to
and release riboﬂavin.
3.2.1. Structural characterization of b-Lg nanostructures
A structural analysis was made in order to understand the in-
ﬂuence of digestion conditions on b-Lg nanostructures loaded with
riboﬂavin, resorting to DLS measurements, and the results are
depicted in Table 3.
From the DLS results depicted above, it was possible to observe
that b-Lg/riboﬂavin nanocomplex possibly suffered aggregation
throughout the digestive process, as well as an increase in its het-
erogeneity. These ﬁndings are inferred from the increase in particle
diameter and PDI values, respectively, along the passage through
the different GI conditions. Although, it was not possible to deter-
mine the precise mechanism that caused the structural changes in
the nanostructures but the increase in particle diameter could be
explained by the presence of bile salts, digestive enzymes, or by the
combined effect of pH and ionic strength (Pinheiro, 2013). During
the stomach step, b-Lg nanostructures were subjected to enzymatic
digestion (pepsin and lipase) and acidic pH conditions (from 4.8 to
1.7), which inﬂuence the conformation of the nanostructure, as
well as its z-potential. The passage through the pI value of b-Lg (pH
of 5.2) may inﬂuence its structure and can be the cause of the
particle diameter difference between the initial and gastric condi-
tions (Grifﬁn, Grifﬁn, Martin, & Price, 1993) and its surface charge,
observable on the transition from a z-potential value of 37 ± 1
toþ28 ± 2mV (i.e. pH values below pI promote a positively charged
protein surface) (Diarrassouba, 2013). Despite of the changes, when
comparing with the initial state, the nanostructure remained ho-
mogenous and stable supported by low PDI value (ca. < 0.2) and
high z-potential value (ca. þ30 mV), respectively e see Table 3. To
conﬁrm the results obtained by DLS, a native PAGE was performed
e see Fig. 1 - since it enables the separation of b-Lg aggregates by
charge, particle diameter and shape (Rodrigues et al., 2015).
From the analysis of Fig. 1, it is possible to observe that in lane 1,
unheated b-Lg nanostructures are more likely to aggregate at pH 6,
which is near the pI of b-Lg (i.e. pH value of 5.2) which leads to the
formation of small and unstable protein aggregates (Diarrassouba,
2013). Smears in lane 2 can be attributed to heat denaturation of
native b-Lg and concomitant appearance of high molecular mass
protein aggregates as reported elsewhere (Rodrigues et al., 2015).
Comparing lane 2 (b-Lg/riboﬂavin nanocomplex) used as control
with lane 4 (b-Lg/riboﬂavin nanocomplex in stomach), is quiteTable 3
Particle size, PDI and z-potential values of b-Lg/riboﬂavin nanocomplex at different
stages of digestion (0 h e control, 2 h e stomach, 3 h e duodenum, 4 h e jejunum
and 5 h e ileum).
Digestion phase Size (nm) PDI z-potential (mV)
Control 232 ± 21a 0.16 ± 0.07a 37 ± 1a
Stomach 329 ± 23a 0.16 ± 0.06a 28 ± 2b
Duodenum 826 ± 334b 0.68 ± 0.13b 27 ± 4c
Jejunum 726 ± 226b 0.65 ± 0.10b 36 ± 3a
Ileum 859 ± 288b 0.68 ± 0.15b 34 ± 3a
Note:Means within a given column, labeledwith the same superscript letter (a, b, c),
do not statistically differ from each other (p > 0.05).evident the presence of b-Lg/riboﬂavin nanocomplex in the stom-
ach phase. This may indicate that b-Lg nanostructures are resistant
to proteolytic and pH conditions of stomach. In lane 4, protein
smears may result from acid aggregation during transition through
isoelectric point, promoted by the in vitro stomach pH conditions.
From lane 5 to 8, b-Lg/riboﬂavin nanocomplex was not observed
when compared with lane 2 (control), which may indicate that
such nanocomplex was completely degraded in the intestinal phase
of the GI system, possibly as soon as it reached the duodenum
(Fig. 1). Despite of b-Lg endurance in the stomach, during intestinal
digestion b-Lg is very susceptible to small intestine enzymatic hy-
drolysis (i.e. pancreatin), which leads to b-Lg digestion in the small
intestine (Fu, Abbott, & Hatzos, 2002; Mandalari et al., 2009). The
loss of color progressively observed from lane 6 to 8 may be due to
the dilution effect of the samples, as a consequence of in vitro
digestion protocol (constant addition of electrolyte solutions)
(Pinheiro et al., 2013).
The DLS and electrophoretic results suggest that b-Lg is resistant
to enzyme digestion in the stomach. This resistance can be
explained by the fact that most hydrophobic amino acids are buried
inside the b-barrel, due to its stable globular tertiary structure,
which makes pepsin digestion a more difﬁcult process (Bateman,
Ye, & Singh, 2010; Peram, Loveday, Ye, & Singh, 2013). Regarding
the passage of b-Lg through the small intestine, the DLS analysis
could be misleading. Due to high PDI values in the small intestine
(probably due to the presence of bile salts and enzymes), DLS
analysis may not be the best analytical method to measure the
structural changes that may occur in the small intestine phase.
Therefore, the electrophoretic technique was performed and the
results showed that b-Lg nanostructures were degraded in the
duodenum since the correspondent band is not observable on the
subsequent digestion stages. This behavior was also reported by
other authors (Bossios et al., 2011; Fu et al., 2002; Islam, Ekeberg,
Rukke, & Vegarud, 2015). Fu et al. (2002) studied the digestibility
of food allergens and non-allergenic proteins under simulated GI
conditions. One of the food allergens studied was b-Lg which
showed to be highly resistant to gastric digestion but rapidly
degraded in the small intestine, being mostly digested by pancre-
atic enzymes. Bossios et al. (2011) studied the effect of simulated GI
conditions on the allergenic reactivity of b-Lg. They concluded that
b-Lg resisted the harsh gastric conditions but was susceptible to
pancreatic enzymes in the small intestine. Islam et al. (2015)
studied the in vitro digestion of milk focusing on proteolysis and
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but was degraded by pancreatic enzymes. They also concluded that
bile salts inﬂuence signiﬁcantly the digestion of b-Lg.
In this work, it was shown that b-Lg is a bio-based carrier that
has the ability to protect an active compound from gastric condi-
tions (i.e. acidic pH and enzymatic activity). In contrast, under in-
testinal conditions, our results and reports described elsewhere
indicate that b-Lg and its genetic variants are degraded mainly due
to bile salts concentration and presence of pancreatin that in-
ﬂuences its digestion rate (Bossios et al., 2011; Fu et al., 2002; Islam
et al., 2015). Therefore, it should be expected that riboﬂavin release
took place in the small intestine. As such, in order to verify this
hypothesis, the release proﬁle of riboﬂavin was determined during
GI simulation and the results are reported below.
3.2.2. Release proﬁle of riboﬂavin
During in vitro digestion, the release proﬁle of riboﬂavin was
evaluated in order to identify the precise location and quantify its
release.
Fig. 2 shows that only 11 ± 2% of riboﬂavin was released during
the gastric phase; this result was somehow expected due to b-Lg
resistance to gastric conditions. On the other hand, higher amounts
of riboﬂavin were released in the duodenum, jejunum and ileum,
corresponding to 35, 38 and 5% of the total riboﬂavin encapsulated,
respectively. These results are in accordance with the results ob-
tained by native-PAGE, which showed the degradation of b-Lg
mostly in the small intestine.
The results presented above show that most riboﬂavin was
released during duodenum and jejunum phases (35 and 38%,
respectively). Being part of the small intestine, the main role of
duodenum, jejunum and ileum is to breakdown food constituents
into smaller compounds. These compounds are then absorbed
through the intestinal walls and the waste products (non-absorbed
substances) pass into the large intestine for excretion (Pinheiro,
2013; Thomson, Shaffer, & Gonska, 2014). Since most of the ribo-
ﬂavin was released in the duodenum and jejunum, it is most likely
that riboﬂavin would be mostly absorbed by the intestinal walls,
into the bloodstream.
These results conﬁrm that b-Lg nanostructures can act as pro-
tective carriers against gastric conditions, which will allow
enhancing the bioavailability of riboﬂavin and thus improving its
absorption in the small intestine.
3.3. Evaluation of b-Lg/riboﬂavin stability
A stability study was conducted in food simulant conditions to
evaluate the behavior of b-Lg over time, mimicking itsFig. 2. Inﬂuence of in vitro gastrointestinal conditions on accessibility of free riboﬂavin and
tract during 5 h of digestion time.incorporation in a food product under storage conditions. A struc-
tural evaluation of the nanocomplex and a release proﬁle were
obtained and the results are shown in Figs. 3 and 4 and Fig. 5,
respectively.
Fig. 3 shows that particle diameter, PDI and z-potential,
remained approximately constant during the experiment timewith
mean particle diameters of 202 ± 7 and 232 ± 4 nm, PDI values of
0.11 ± 0.04 and 0.09 ± 0.03, and z-potential values of 37 ± 2
and þ37 ± 1 mV, for water and food simulant conditions, respec-
tively. Moreover, the results showed that b-Lg, slightly aggregated
under food simulant conditions when compared with water con-
ditions (mean particle diameter of 202 ± 7 nm instead of
232 ± 4 nm in water and food simulant conditions, respectively).
This smaller aggregation could be explained by the effect of acetic
acid in the protein unfolding properties (Borkar, Rout, & Hosur,
2012; Liao et al., 2010), which could possibly enable protein ag-
gregation by inducing the formation of intermolecular bonds
(Rodrigues et al., 2015). Since we are working with acetic acid at
low concentration, the differences observed between water and
food simulant conditions were not too prominent. In spite of this,
the solution remained homogeneous, with a low PDI value in both
water and simulant conditions. Thus, the food simulant conditions
did not signiﬁcantly change the homogeneity of the solution
(p < 0.05). Regarding the z-potential, the change between a nega-
tive surface charge (water conditions) to a positive surface charge
(simulant conditions) can be explained by the different pH of the
solutions (pH 6 and 3.65, above and below the pI of b-Lg, for water
and simulant conditions, respectively) (Diarrassouba, 2013;
Donato, Schmitt, Bovetto, & Rouvet, 2009). These results were
corroborated with TEM micrographs (Fig. 4).
These images indicate that b-Lg nanostructures have a spherical
shape, with a particle diameter of ca. 200 nm (in accordance with
DLS measurements) in both water and food simulant conditions,
suggesting that b-Lg nanostructures are resistant to food simulant
conditions. It is also possible to observe that b-Lg suffered some
structural changes in water (when compared with time 0 from
Fig. 4), imperceptible on DLS analysis. It is noticeable that b-Lg in
water formed crystal shaped structures after 14 days of storage at
4 C. Proteins in aqueous solutions tend to quickly aggregate (due to
protein unfolding) when submitted to low temperatures
(Kolakowski et al., 2001). This characteristic may explain the ag-
gregation of b-Lg in water, after 14 days of storage at low temper-
ature. This effect was not observable for b-Lg under simulant
conditions. The presence of acetic acid could enhance the charge
density and electrostatic repulsion between proteins (Liao et al.,
2010), preventing protein aggregation during storage time. These
micrographs also conﬁrm that the particle diameter of b-Lgrelease of riboﬂavin from b-Lg/riboﬂavin nanocomplex over different stages of the GI
Fig. 3. Structural analysis of b-Lg nanocomplex determined by measuring a) size, b) PDI and c) z-potential via DLS, during a 14 days of storage, in water and food simulant
conditions.
Fig. 4. TEM micrographs of b-Lg under water (column A - control) and food simulant (column B) conditions, at time 0 (top micrographs) and time 14 (bottom micrographs) (scale
bar ¼ 200 nm, magniﬁcation ¼ 80,000 x).
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Fig. 5. Riboﬂavin release proﬁle in water and food simulant conditions during 14 days of storage.
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(when comparisons were made with time 0, Fig. 4), suggesting that
proteins remain stable during this 14 days period. Thus, TEM mi-
crographs allowed conﬁrming the lack of structural changes on b-
Lg nanocomplex during the stability assay, under these food sim-
ulant conditions.
Despite b-Lg stability under simulant conditions, a riboﬂavin
release proﬁle was obtained. Results regarding release of riboﬂavin
are shown in Fig. 5 and allowed to determine if b-Lg could serve as a
protective carrier for this vitamin during a given storage period
(shelf life).
The results shown in Fig. 5 are in accordance with TEM and DLS
results. Since b-Lg did not show signiﬁcant structural changes over
time under food simulant conditions, it was expected that ribo-
ﬂavin remained associated to b-Lg in the food simulant as much as
in water. Therefore, b-Lg gradually released its riboﬂavin content
and, at day 7, the complete riboﬂavin release occurred. No signiﬁ-
cant differences (p > 0.05) were observed when comparing water
and simulant results, conﬁrming once more that b-Lg was resistant
to food simulant conditions.
4. Conclusions
Stable and homogenous b-Lg nanostructures were successfully
produced at pH 6 to act as protective carriers for nutraceuticals (e.g.
riboﬂavin). It was possible to conclude that not only b-Lg nano-
structures have the ability to associate to riboﬂavin, with an asso-
ciation efﬁciency of 26 ± 1%, but they also serve as protective
carriers during gastric digestion, releasing the riboﬂavin content in
the appropriate absorption location (i.e. small intestine) once b-Lg
is completely degraded as soon as the nanostructures reach the
duodenum. Moreover, the results showed that 12% of RDD would
reach the small intestine if 100 mL of solution was ingested and,
thus, this nanostructure could be added to food products to act as a
food supplement, in order to help reaching the RDD.
Results show that b-Lg nanostructure is structurally stable for a
period of 14 days under simulant conditions (i.e. yoghurt). The
presence of acetic acid may have increase electrostatic repulsion
between b-Lg, thus preventing its aggregation and enhancing its
structural stability. However, regarding riboﬂavin release, b-Lg/
riboﬂavin nanocomplex is less stable under similar conditions once
riboﬂavin is fully released from protein core after a period of 7 days
of storage.
Further tests in a dynamic GI model (as identical as possible to
the human GI system) and in Caco-2/HT29-MTX co-cultured cell
lines (to mimic, as close as possible, human intestinal cells) will be
crucial to evaluate the permeability and absorption rates of ribo-
ﬂavin and to obtain more accurate results in order to better un-
derstand and predict the behavior of nanostructured systems under
GI simulated conditions. It would also be important to study the
behavior of b-Lg/riboﬂavin nanocomplex under other food simu-
lant conditions such as beverages or starch-based foods, as well asin a real food matrix.
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